36C25924Q0284 RFQ 7-Year Micro OKC MUSK Part 13 FINAL.pdf

PAGE 1 OF 1. REQUISITION NO.

2. CONTRACT NO. 3. AWARD/EFFECTIVE DATE 4. ORDER NO. 5. SOLICITATION NUMBER 6. SOLICITATION ISSUE DATE

a. NAME b. TELEPHONE NO. (No Collect Calls) 8. OFFER DUE DATE/LOCAL

TIME

9. ISSUED BY CODE 10. THIS ACQUISITION IS UNRESTRICTED OR SET ASIDE: % FOR:

SMALL BUSINESS

HUBZONE SMALL

BUSINESS

SERVICE-DISABLED

VETERAN-OWNED

SMALL BUSINESS

WOMEN-OWNED SMALL BUSINESS

(WOSB) ELIGIBLE UNDER THE WOMEN-OWNED

SMALL BUSINESS PROGRAM

EDWOSB

8(A)

NAICS:

SIZE STANDARD:

11. DELIVERY FOR FOB DESTINA-

TION UNLESS BLOCK IS

MARKED

SEE SCHEDULE

12. DISCOUNT TERMS

13a. THIS CONTRACT IS A

RATED ORDER UNDER

DPAS (15 CFR 700)

13b. RATING

14. METHOD OF SOLICITATION

RFQ IFB RFP

15. DELIVER TO CODE 16. ADMINISTERED BY CODE

17a. CONTRACTOR/OFFEROR CODE FACILITY CODE 18a. PAYMENT WILL BE MADE BY CODE

TELEPHONE NO. UEI: EFT:

PHONE: FAX:

17b. CHECK IF REMITTANCE IS DIFFERENT AND PUT SUCH ADDRESS IN OFFER

18b. SUBMIT INVOICES TO ADDRESS SHOWN IN BLOCK 18a UNLESS BLOCK BELOW IS CHECKED

SEE ADDENDUM

19. 20. 21. 22. 23. 24.

ITEM NO. SCHEDULE OF SUPPLIES/SERVICES QUANTITY UNIT UNIT PRICE AMOUNT

(Use Reverse and/or Attach Additional Sheets as Necessary)

25. ACCOUNTING AND APPROPRIATION DATA 26. TOTAL AWARD AMOUNT (For Govt. Use Only)

27a. SOLICITATION INCORPORATES BY REFERENCE FAR 52.212-1, 52.212-4. FAR 52.212-3 AND 52.212-5 ARE ATTACHED. ADDENDA ARE ARE NOT ATTACHED.

27b. CONTRACT/PURCHASE ORDER INCORPORATES BY REFERENCE FAR 52.212-4. FAR 52.212-5 IS ATTACHED. ADDENDA ARE ARE NOT ATTACHED

28. CONTRACTOR IS REQUIRED TO SIGN THIS DOCUMENT AND RETURN _______________ 29. AWARD OF CONTRACT: REF. ___________________________________ OFFER

COPIES TO ISSUING OFFICE. CONTRACTOR AGREES TO FURNISH AND DATED ________________________________. YOUR OFFER ON SOLICITATION

DELIVER ALL ITEMS SET FORTH OR OTHERWISE IDENTIFIED ABOVE AND ON ANY (BLOCK 5), INCLUDING ANY ADDITIONS OR CHANGES WHICH ARE

ADDITIONAL SHEETS SUBJECT TO THE TERMS AND CONDITIONS SPECIFIED SET FORTH HEREIN IS ACCEPTED AS TO ITEMS:

30a. SIGNATURE OF OFFEROR/CONTRACTOR 31a. UNITED STATES OF AMERICA (SIGNATURE OF CONTRACTING OFFICER)

30b. NAME AND TITLE OF SIGNER (TYPE OR PRINT) 30c. DATE SIGNED 31b. NAME OF CONTRACTING OFFICER (TYPE OR PRINT) 31c. DATE SIGNED

AUTHORIZED FOR LOCAL REPRODUCTION (REV. NOV 2021)

PREVIOUS EDITION IS NOT USABLE Prescribed by GSA - FAR (48 CFR) 53.212

7. FOR SOLICITATION

INFORMATION CALL:

STANDARD FORM 1449

SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES

OFFEROR TO COMPLETE BLOCKS 12, 17, 23, 24, & 30

36C259-24-AP-0156

36C25924Q0284 03-07-2024

Tania Urenda 303-712-5730 03-18-2024

9am MST

36C259

Department of Veterans Affairs

Network Contracting Office

NCO 19

6162 South Willow Drive, Suite 300

Greenwood Village CO 80111

X

334516

N/A

36C259

Department of Veterans Affairs

Oklahoma City VA Health Care System

921 NE 13th ST, Oklahoma City, OK, 73104

Eastern Oklahoma VA Health Care System

1011 Honor Heights Dr, Muskogee,OK 73104

36C259

Department of Veterans Affairs

Network Contracting Office

NCO 19

6162 South Willow Drive, Suite 300

Greenwood Village CO 80111

Submitted Electronically

Department of Veterans Affairs

Financial Service Center

PO Box 149971

Austin TX 78714-9971

See CONTINUATION Page

Contractor shall provide Cost Per Test Automated

Microbiological Blood Culture and Identification &

Antimicrobial Susceptibility Testing (ID/AST) for Oklahoma

City VA Health Care System and Eastern Oklahoma VA Health

Care System.

This solicitation is full and open.

This is a FAR Part 13 procurement. There will be one awardee.

Review and follow the Addendum to FAR 52.212-1, Instructions

Review and follow the Addendum to FAR 52.212-1, Instructions Review and follow the Addendum to FAR 52.212-1, Instructions Review and follow the Addendum to FAR 52.212-1, Instructions

To Offerors – Commercial Items & Addendum to FAR 52.212-2

Evaluation – Commercial Items.

See CONTINUATION Page

X X

X 1

Juanita Street

VA-VHA-RPOW-2023-0066

36C25924Q0284

Table of Contents

SECTION A

A.1 SF 1449 SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL PRODUCTS

AND COMMERCIAL SERVICES

SECTION B - CONTINUATION OF SF 1449 BLOCKS

B.1 CONTRACT ADMINISTRATION

B.2 STATEMENT OF WORK – CPT Microbiology

B.3 SCHEDULE - OKCVAHCS

B.4 SCHEDULE - EOKVAHCS

B.5 VISN19 MICROBIOLOGY CPT PRICE TOTALS FOR SEVEN YEARS

B.6 INTRODUCTION

B.7 TERMS AND CONDITIONS

B.8 ADMINISTRATIVE DATA

B.9 PRICING DATA

B.10 OPTION TO EXTEND THE TERM OF THE BPA

B.11 AUTHORIZED LIMITS

B.12 OBLIGATION OF FUNDS

B.13 PERIOD OF PERFORMANCE

B.14 AUTHORIZED INDIVIDUALS

B.15 ORDER FORMAT

B.16 AUTHORIZED REPRESENTATIVES

B.17 FEDERAL HOLIDAYS

B.18 BPA EMPLOYEE IDENTIFICATION

B.19 MANAGEMENT CONTROL

B.20 INVOICES

B.21 GENERAL SUPPLY ORDERS

SECTION C - CONTRACT CLAUSES

C.1 BPA ORDER RFQ INTRODUCTORY LANGUAGE

C.2 52.212-4 CONTRACT TERMS AND CONDITIONS—COMMERCIAL PRODUCTS

AND COMMERCIAL SERVICES (NOV 2023)

C.3 52.217-8 OPTION TO EXTEND SERVICES (NOV 1999)

C.4 SUPPLEMENTAL INSURANCE REQUIREMENTS

C.5 52.232-19 AVAILABILITY OF FUNDS FOR THE NEXT FISCAL YEAR (APR

1984)

C.6 IT CONTRACT SECURITY

C.7 VAAR 852.201-70 CONTRACTING OFFICER'S REPRESENTATIVE (DEC 2022)

C.8 VAAR 852.203-70 COMMERCIAL ADVERTISING (MAY 2018)

C.9 VAAR 852.208-70 SERVICE-DISABLED VETERAN-OWNED AND VETERAN-

OWNED SMALL BUSINESS EVALUATION FACTORS – ORDERS or BPAs (JAN

2023) (DEVIATION)

C.10 VAAR 852.208-71 SERVICE-DISABLED VETERAN-OWNED AND VETERAN-

OWNED SMALL BUSINESS EVALUATION FACTOR COMMITMENTS-ORDERS AND

BPAS (JAN 2023) (DEVIATION)

C.11 VAAR 852.211-76 LIQUIDATED DAMAGES - REIMBURSEMENT FOR DATA

BREACH COSTS (FEB 2023) ALTERNATE I (FEB 2023)

C.12 VAAR 852.212-71 GRAY MARKET ITEMS (APR 2020)

C.13 VAAR 852.212-72 GRAY MARKET AND COUNTERFEIT ITEMS—

INFORMATION TECHNOLOGY MAINTENANCE ALLOWING OTHER-THAN-NEW

PARTS (FEB 2023)

C.14 VAAR 852.215-70 SERVICE-DISABLED VETERAN-OWNED AND VETERAN-

OWNED SMALL BUSINESS EVALUATION FACTORS (JAN 2023) (DEVIATION)

C.15 VAAR 852.215-71 EVALUATION FACTOR COMMITMENTS (OCT 2019)

C.16 VAAR 852.232-72 ELECTRONIC SUBMISSION OF PAYMENT REQUESTS

(NOV 2018)

C.17 VAAR 852.242-71 ADMINISTRATIVE CONTRACTING OFFICER (OCT 2020) ..55

C.18 VAAR 852.246-71 REJECTED GOODS (OCT 2018)

C.19 VAAR 852.247-71 DELIVERY LOCATION (OCT 2018)

C.20 VAAR 852.247-72 MARKING DELIVERABLES (OCT 2018)

C.21 52.252-2 CLAUSES INCORPORATED BY REFERENCE (FEB 1998)

C.22 52.212-5 CONTRACT TERMS AND CONDITIONS REQUIRED TO IMPLEMENT

STATUTES OR EXECUTIVE ORDERS—COMMERCIAL PRODUCTS AND

COMMERCIAL SERVICES (FEB 2024))

SECTION D - CONTRACT DOCUMENTS, EXHIBITS, OR ATTACHMENTS

D.1 VISN 19 Facility Microbiology Estimated Annual Volume

D.2 OKCVAHCS Floor Plan

D.3 EOKVAHCS Floor Plan

SECTION E - SOLICITATION PROVISIONS

E.1 52.212-1 INSTRUCTIONS TO OFFERORS—COMMERCIAL PRODUCTS AND

COMMERCIAL SERVICES (SEP 2023)

E.2 52.204-24 REPRESENTATION REGARDING CERTAIN TELECOMMUNICATIONS

AND VIDEO SURVEILLANCE SERVICES OR EQUIPMENT (NOV 2021)

E.3 52.209-7 INFORMATION REGARDING RESPONSIBILITY MATTERS (OCT 2018)

E.4 52.216-1 TYPE OF CONTRACT (APR 1984)

E.5 52.233-2 SERVICE OF PROTEST (SEP 2006)

E.6 VAAR 852.233-70 PROTEST CONTENT/ALTERNATIVE DISPUTE RESOLUTION

(OCT 2018)

E.7 VAAR 852.233-71 ALTERNATE PROTEST PROCEDURE (OCT 2018)

E.8 VAAR 852.215-72 NOTICE OF INTENT TO RE-SOLICIT (OCT 2019)

E.9 52.252-1 SOLICITATION PROVISIONS INCORPORATED BY REFERENCE (FEB

1998)

E.10 52.212-2 EVALUATION—COMMERCIAL PRODUCTS AND COMMERCIAL

SERVICES (NOV 2021)

E.11 52.212-3 OFFEROR REPRESENTATIONS AND CERTIFICATIONS—

COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES (FEB 2024)

SECTION B - CONTINUATION OF SF 1449 BLOCKS

B.1 CONTRACT ADMINISTRATION

(continuation from Standard Form 1449, block 18A.)

B.1.1. Contract Administration: All contract administration matters will be handled by the following individuals:

B.1.1.1. CONTRACTOR: Name: ________________________ Title: _________________________ Company: _____________________ Address: ______________________ Telephone#: ___________________

FAX #: ________________________

E-mail address: _________________

B.1.1.2. GOVERNMENT: Tania Urenda, Contracting Officer

Department of Veterans Affairs Rocky Mountain Network NCO 19 Contracting 6162 S. Willow Drive, Suite 300 Greenwood Village, CO 80111 Telephone: 303.712.5730

E-mail: Tania.Urenda@va.gov NCO19Services2@va.gov

B.1.2. CONTRACTOR REMITTANCE ADDRESS: All payments by the Government to the contractor will be made in accordance with:

[X] 52.232-33, Payment by Electronic Funds Transfer - System for Award Management (SAM), or

[N/A] 52.232-36, Payment by Third Party

B.1.3. GOVERNMENT INVOICE ADDRESS: Invoices shall be submitted in arrears:

a. Quarterly []

b. Semi-Annually []

c. Other [X] MONTHLY IN ARREARS

B.1.4. GOVERNMENT INVOICE ADDRESS: All invoices from the contractor shall be submitted electronically to the VA Financial Services Center for payment processing, free of charge. For any questions about the e-invoicing program, please contact the FSC at the phone number or email address listed below:

• OB10/Tungsten e-Invoice Setup Information: (877) 752-0900

• OB10/Tungsten e-Invoice email: USClientServices@ob10.com

• FSC e-Invoice Contact Information: (877) 353-9791 mailto:Tania.Urenda@va.gov mailto:NCO19Services2@va.gov http://USClientServices@ob10.com

• FSC e-invoice email: vafsccshd@va.gov

• The following two codes will be required when creating a vendor profile in OB10:

OB10 Buyer Number AAA544240062 Promo Code: VAPC7Y18

B.1.5. DUNS NUMBER: Please provide the Dun and Bradstreet Number assigned to your firm in the space provided: _______________________

B.1.6. CONTRACTOR’S UNIQUE ENTITY ID (SAM): Please provide the Contractor’s Unique Entity ID number to be utilized for this contract: _________________________

B.1.7. TAX IDENTIFICATION NUMBER: Please provide the tax identification number to be utilized for this contract: _________________________

B.1.8. PERIOD OF PERFORMANCE: Services required herein shall be for the following time period:

Year 1: April 1, 2024 through March 31, 2025 Year 2: April 1, 2025 through March 31, 2026 Year 3: April 1, 2026 through March 31, 2027 Year 4: April 1, 2027 through March 31, 2028 Year 5: April 1, 2028 through March 31, 2029 Year 6: April 1, 2029 through March 31, 2030 Year 7: April 1, 2030 through March 31, 2031 http://vafsccshd@va.gov

B.2 STATEMENT OF WORK – CPT Microbiology

1. INTRODUCTION:

The Contractor shall provide Cost Per Test (CPT) Automated Microbiological Blood Culture and Identification/Antimicrobial Susceptibility Testing (ID/AST) for the Pathology & Laboratory Medicine Service for Department of Veterans Affairs (DVA) for two VISN 19 facilities, Oklahoma City VA Health Care System (OKCVAHCS) located at 921 NE 13TH ST, Oklahoma City, OK, 73104 and the Eastern Oklahoma VA Health Care System (EOKVAHCS) located at 1011 Honor Heights Drive, Muskogee, OK, 73104.

2. SCOPE OF WORK:

a. General Information: The Contractor shall provide the equipment, software, consumables, and training to enable the listed facilities to perform the following tests per the test menu at a fixed CPT price:

• Aerobic blood culture testing

• Anaerobic blood culture testing

• Subculture capability

• Mycobacteria processing (non-blood sources)

• Gram-positive susceptibility testing (AST)

• Gram-negative susceptibility testing (AST)

• Yeast susceptibility testing

• Gram-positive ID

• Gram-negative ID

• Anaerobic ID

• Neisseria/Haemophilus ID

• Yeast ID

b. The following instruments shall be installed at the OKCVAHCS and EOKVAHCS facilities: Automated microbiological blood culture detection system, ID/AST system, and integrated software to link all equipment, as listed above, which shall have the capability of performing or reporting the clinical parameters as defined for the

OKCVAHCS and EOKAHCS in accordance with the terms and conditions stated herein.

c. The Contractor will provide all equipment, reagents, standards, controls, supplies, consumable/disposable items, parts, accessories, software, software updates, printers for each system, uninterruptable power supply (UPS) for each instrument, per manufacturer’s specifications, and any other item required for the proper operation of its’ contractor owned analyzer and peripherals necessary for the generation of the CPT testing on behalf of the OKCVAHCS and EOKVAHCS.

d. The instruments shall be able to simultaneously perform the complete profile as described below and meet the performance characteristics for accuracy and precision as defined by the 1988 Clinical Laboratory Improvement Act (CLIA) and the Clinical and Laboratory Standards Institute (CLSI). The assessment shall be capable of performing the required volumes as listed in Section B and Section D below. The

Contractor shall propose the suggested and recommended equipment and reagents that meet the requirements of each facility.

e. The contractor will provide to OKCVAHCS and EOVAHCS laboratories, all supplies and services as described herein, and in accordance with the applicable Federal Supply Schedule contract. CPT shall also include service of all equipment for the life of the agreement as identified below.

Cost Per Test: CPT is an all-inclusive price based on a minimum of disposables per month. The contractor is required to furnish all supplies necessary to operate the contractor’s equipment for the testing menu as defined, including blood culture analytical system for routine blood and mycobacterium, Identification (ID), antimicrobial susceptibility testing (AST), supplies to operate the instruments, server - whether it be physical or virtual, software for integrating all instruments for easy and smooth workflow, bi-directional with lab information system, Veterans Health Information Systems and Technology Architecture (VISTA), training, and all preventive maintenance and repairs.

All pieces of equipment required for system operation as requested, including but not limited to: instruments, service agreements and maintenance of all equipment, hardware and software including all installation costs, service, maintenance, and future software updates and requested training trips per year, are to be separated into an initially defined total cost disclosure for the total contract period. Increase in test volume will not incur increase in additional fixed costs unless new equipment has been added in addition to the current provided services.

f. Support Services: The contractor shall provide telephone assistance 24 hours /day, 7 days/week 365 days per year. Following determination that service is required, technical, onsite support must be provided under the terms of the Federal Supply Schedule and provide for emergency repairs seven days per week within twenty-four

(24) hours of the time of notification of the malfunction. The contractor shall provide maintenance (labor and parts) to keep the equipment in good operating condition and subject to security regulations. The Government will provide the contractor access to the equipment to perform maintenance service per the maintenance and service terms herein.

g. Testing Menu: The contractor will provide the test menu as defined in the Schedule listed in Section B. Annual test volumes provided with this contract are based upon prior history and are not a guaranteed minimum. New tests will be added as requested to the menu with all the correlation studies performed for test validation at no additional cost. Specimen integrity checks will be made on all specimens at no additional charge.

The contractor will notify the Government when there is a change in service and/or supply items.

3. REQUIREMENTS OF COST PER TEST PROVIDED:

Table 1: List of Required Analyzers by Location:

Equipment Number

Required Estimated Quantity of

Tests per Year Requirement

OKC: EOK: OKC: EOK:

Blood culture detection instrument with

Cart

1 1 16,000 12,000 Minimum 450 bottle capacity at one time.

Identification (ID) and Antimicrobial

Susceptibility

Testing (AST)

1 1 4,800 10,100 Minimum of 120 cards/panels at one time.

a. Basic Requirements:

• The system must contain random access technologies that improve workflow.

• Fast, accurate resulting.

• U.S. Food and Drug Administration (FDA) approved tests/reagents.

• Pre-applied barcoded testing kits, reagents, and disposables for reducing errors and traceability.

• Patient and sample information must be linked from sample set-up through final reporting.

• Results and system information easily accessed remotely.

• Ability to accept parallel sample preparation by multiple technologists at different benches.

• Individual log-in for complete traceability.

• Bi-directional interface with laboratory information system (LIS) which allows for the linking of instruments.

• Software: ability to manage multiple instruments and multiple LIS through a unified interface; easy interface, secure, and multi-concurrent user access.

• Ability to connect rapid microbiology identification (ID) and antimicrobial susceptibility testing (AST) systems.

• Compliant with middleware (Data Innovations/Cerner) for LIS connectivity.

• Operating humidity range: 20% to 80% relative humidity.

• Operating ambient temperature: 20˚C to 30˚C.

• Instrument must be operational and provide accurate results at high altitude.

b. Blood Culture Analytical Systems for OKCVAHCS and EOKVAHCS:

Blood Culture System:

• Fully automated system with ability to accommodate random loading of bottles.

• Colorimetric detection technology.

• The system shall provide self-contained, continuous, computerized, automated monitoring of blood culture bottles with immediate, active (e.g., adjustable audible alarm) notification of microorganism growth based upon preprogrammed criteria and notification of termination of maximum programmed incubation period when no microorganism growth is detected.

• The system shall provide a separate alarm system to help notification of microorganism growth for off shifts. A system that includes both visual and audible alarm(s) is preferred.

• System shall be approved by FDA for both blood and sterile body fluids.

• Continuous monitoring by the microbial detection system to ensure less hands-on time.

• System measures blood volume in each bottle at the time of loading to ensure collection of the recommended volume to be compliant with College of American Pathologists (CAP) accreditation requirement – fill level detection.

• Blood culture analyzer must have enough space to hold patient specimens for up to

5 days routinely with the ability increase to 14 days upon provider request.

• Automatic quality control (QC) and calibration of instrument cells. A “cell” is where a blood culture bottle sits during incubation within the analyzer.

• Minimal daily and monthly maintenance with minimal maintenance downtime.

• Expected throughput: Ability to manage high volume laboratory with 16,000 blood culture tests/year for OKC and 12,000 for Muskogee using one blood culture analyzer.

• Instrumentation must have sufficient throughput to perform at least 100% of the daily test volume during the day shift (6:30am- 4pm) Sunday through Saturday.

Blood Culture Bottles:

• Bottles shall be made of transparent plastic (not glass) required for collection of specimens for bacteria, yeast, and mycobacterium (for all specimen sources) for increased safety.

• Aerobic, anaerobic, and mycobacterium bottles must use the same detection system on a single blood culture analyzer.

• Bottles should have antibiotic neutralization with optimal growth performance of organism.

• Automated waste disposal of blood culture bottles is preferred.

c. Microbiology ID and AST Analytical System for OKCVAHCS and EOKVAHCS requires:

• An automated platform with continuous flow and throughput of test kits.

• A large database with the ability to provide fast and accurate results.

• AST availability for gram-positive, gram-negative, and yeast on the same instrument.

• Same day results - Rapid time to results and reporting of AST within 12 hours, or shorter, for most organisms.

• Specimen integrity evaluation on all supplies as needed at no additional cost.

• Test cards/panels/kits and culture plates to be able to accept a lab-generated barcode for patient identification of specimens/tests.

• Ready to use cards, panels, or tests with no extra biochemical mixing for less reagent handling.

• Simple test set-up with fewer repetitive tasks.

• System to track QC runs by lot number, test type, QC organism, and expected

vs. actual results, System must have the ability to generate cumulative QC reports for review.

• Minimal set-up time of cards, panels, or tests.

• Minimal reagent preparation required.

• Accurate phenotype profile of bacterial resistance mechanism for each organism tested with easy-to-read information.

• Customized alerts and notes for the medical technologists.

• Ease of customization and standardization of workflow.

• Large capacity space for data back-up of computer stored data. Test kits must contain a manufacturer applied barcode label.

• Identification and susceptibility must be an independent unit, not a combo.

• Data backups must have the capability of being scheduled and performed automatically.

• System must contain a report module that will have the ability to generate epidemiology and statistical reports for antibiogram, cumulative percent susceptible by minimum inhibitory concentration (MIC), susceptibility and organism trending report, workload unit report, custom logbook reports, etc.

• Advanced analysis system for resistance detection, alerts, rules, etc.

• Expected throughput: Ability to manage testing workflow of a high-volume laboratory with greater than 4,800 tests/year for OKCVAHCS and greater than 10,000 tests/year for EOKVAHCS, where at least 90% of the testing is performed during the dayshift (6:30am-7:00pm) Sunday through Saturday.

d. Middleware- Integrated Data Management at OKCVAHCS and EOKVAHCS:

• System must be able to interface with LIS, VISTA, Data Innovations, and Cerner.

• Must have a single software solution to manage multiple instruments and LIS through a unified interface.

• Equipment should optimize the management of microbiology workflow.

• Collect, consolidate, and transmit results in real-time for faster time-to-result and rapid reporting.

• System must allow for remote user to review and release results.

• Monitor network with real-time status alerts and alarms for all connected systems.

• Real-time overview of all connected instruments, anywhere, anytime.

• Continuous remote notification of positive blood cultures and other critical events for the technologists in main laboratory.

• Multi-concurrent user access.

• Integrated central processing unit with sufficient data storage capacity to accommodate and provide immediate access to more than 2,000 patient records per day.

• Specimen Integrity based rules to identify unusual phenotypes and make therapeutic corrections.

• FDA approved database software required.

• Monitor and track critical testing process:

− Blood culture contamination

− Multi-drug resistant organisms

• Statistics and trend reporting.

• Scheduled reports.

• Intuitive information selection.

• Software management with rules capable of preparing data for auto validation prior to host transmission.

• System must interface instruments to Data Innovations Interface manager or directly to Laboratory information system.

• All software and software licenses, interfaces, and hardware (e.g. servers, printers, monitors, UPS, etc.) shall be included in the CPT pricing.

4. REAGENTS AND SUPPLIES:

a. Ordering Method: The facility will order products via Electronic Data Interchange

(EDI), telephone, facsimile, or other written communication, identifying the products by number, quantity, address for delivery, and any special instructions.

b. Delivery Tickets: Unless otherwise agreed to, all deliveries under this agreement shall be accompanied by delivery tickets or sales slips that shall contain the following information as a minimum:

1. Name of contractor

2. Contract number

3. BPA Number

4. Purchase order number

5. Date of purchase

6. Quantity, unit price and extension of each item (unit prices and extensions need not be shown when incompatible with the use of automated systems, provided that the invoice is itemized to show information)

7. Date of shipment.

c. Inventory Management: The Contractor is required to provide a continuously stocked inventory of reagents, required consumable supplies including all routinely replaced parts, disposables and any other materials required to properly perform tests on the equipment. Unexpected changes in methodology/technology shall be at the expense of the vendor. Alert/Notification of all technical advisory/recalls/alerts, prior to or simultaneously with field alerts should be forwarded to laboratory supervisor or designee. Failure to reserve adequate inventory will result in default.

d. Items Included: The vendor shall provide and install any routine and special items required to operate and maintain the equipment in optimal condition, such as, but not limited to, linearity standards, printers, consumable equipment parts, required replacement parts for maintenance or service etc. Any items excluded by the vendor but required for operation of the system at any time, must be delineated in their technical proposal. The cost of any excluded items must be disclosed in the cost proposal.

e. Special Handling for Emergency Orders of Supplies: If additional requests for emergency supply delivery are required by the government, the contractor shall honor them until the arrival at the government site of the monthly standing order or routine supply delivery. In the event that the consumables are found to be defective and unsuitable for use with the contractor's equipment, or the contractor has failed to comply with the requirements for routing supply delivery or inventory management, the contractor is required to deliver the consumable supplies within 24 hours of receipt of a verbal order for priority delivery from the government activity. If either circumstance has occurred, the contractor shall deliver to the government site, in the most expeditious manner possible, without additional cost to the government, the necessary consumables in sufficient quantity as required to allow operation of the contractor's equipment for one week (under normal government test load volume).

f. Quality of Reagents, Supplies and Disposables: The contractor shall assure that all supplies provided for use on their equipment will be of the quality necessary to produce reliable results. The reagent quality must be high enough to satisfy proficiency testing standards of CAP and the Joint Commission (JC). In the event that the supplies are found to be defective and unsuitable for use with the contractor's equipment or the contractor has failed to comply with the requirements herein, the contractor is required to deliver the supplies within 24 hours of receipt of the verbal order, if verbal order is received by 1 pm EST time, for priority delivery from the government activity. This shall be done at no cost to the government, in sufficient quantity as required to allow operation of the contractor's equipment for one week (under normal government test load volume). The vendor shall reimburse the facility for any costs/supplies related to tests performed by another vendor or sent to a referral laboratory when reagents were not available due to product issues or instrumentation failure.

g. Returned Goods: The VA is responsible for inspecting all products shipped hereunder and give the contractor written notice of rejection within thirty (30) calendar days following receipt or installation by the contractor. QC testing is performed by laboratory personnel upon arrival of new supplies and weekly to ensure reliable patient testing on a continuous basis.

h. Shipping Charges: No delivery charges for shipping or fee handling will be accepted by the VA. Any additional costs such as Industrial Funding Fees, special shipping and handling fees, or other usage fees must be clearly indicated in the price quote and included in CPT. For reagents with hazardous constituents, vendor must provide a mechanism for the Laboratory to meet local discharge requirements.

5. ADDITIONAL SYSTEM REQUIREMENTS:

a. Upgrades or Replacement: Request for instrumentation upgrades or replacement, due to workload increase, excessive instrumentation failures/malfunctions, breakdowns, or service calls will be evaluated as needed with communication to the

Network Contracting Office (NCO 19) who will then contact the vendor for modification of the contract. A high incidence of such problems with any equipment/analyzer supplied may indicate probable non-compliance with the terms of this contract and may entitle the laboratory to seek replacement of the analyzer(s) at Contractor’s expense. Removal of instrument by the vendor shall be performed within 30 days after request and at no additional cost to the VA.

b. Patient Mean Analysis Quality Control program: The Contractor is required to have a QC program available on instruments or through middleware to monitor trends of test methods.

c. Comprehensive onboard QC Program, including Troubleshooting or System

Validation QC material. The system must have quality control data storage and reporting capabilities, the ability to view and print daily and monthly cumulative QC results. The program must also allow for troubleshooting unsatisfactory results and system errors. Documentation of the above information must be able to be archived and retrieved during the life of this agreement.

d. Updated Software/ Equipment: The Contractor shall provide all updates to the equipment hardware and operating system software without additional charge to the government. These enhancements to the contractor's equipment shall be delivered to the government site and installed by the contractor within 60 days of their issuance or date of first commercial availability.

e. Remote Instrument monitor: The contractor will provide remote access method to meet Health Insurance Portability and Accountability Act (HIPPA) and VA confidentiality requirements for customer support staff and remote diagnostic services.

f. Customer support Staff of the contractor must obtain a VPN (virtual private network) to be able to configure the system to allow for diagnostics and troubleshooting/support services. Vendor staff with access to VA medical records must provide satisfactory documentation of receiving HIPAA training and complying with all HIPAA and VA patient confidentiality requirements.

g. An approved remote network communication system must be provided, that continuously collects and monitors performance data of the analytical systems following all the policies and procedures outlined in VA Directive 6500, Information

Security Program, and its handbooks to ensure appropriate security controls are in place. Handbook can be found at va.gov/vapubs/index.cfm.

h. Barcodes: All barcode readers must be capable of reading and decoding any label when manually applied to a specimen tube in accordance with the guidelines described in the Clinical and Laboratory Standards Institute (CLSI) standard, Laboratory Automation: Bar Codes for Specimen Container Identification, CLSI

Document AUTO02-A2, Approved Guideline, Vol. 25, No. 29, December 2005.

i. New Test Methods: Contractor shall supply technical support specialists to perform all validation studies including installation, set-up, correlation studies

(evaluation/comparison data sufficient to satisfy CAP standards), and normal range studies at no initial charge for new test methods that become available.

6. MAINTENANCE AND SERVICE SUPPORT REQUIREMENTS:

a. Computer Patient Data Handling: No hardware, containing any VA patient information is to be removed from any location, without the approval and removal of data by the VA information technology department.

https://www.va.gov/vapubs/index.cfm

b. Preventative Maintenance: Contractor shall provide regular, scheduled maintenance to assure the continued reliable operation of the equipment. These preventive maintenance visits shall be of a frequency that conforms to the manufacturer's operation and maintenance instructions for the supported equipment. Minimum of 1 to 2 per year per instrument unless documentation for volume performed denotes not required for optimum quality of operation.

c. Emergency Repair: Emergency repairs shall be performed after notification that the equipment is inoperative. The contractor shall provide the government with a designated point of contact and shall decide to enable its maintenance representative to receive such notification.

• The contractor will perform emergency repair service within 24 hours of time of notification of the malfunction except when an ordering facility elects reduced service at contract agreed reduction.

• The contractor will provide all parts and labor needed to repair the malfunction.

Travel, per diem and other expenses associated with the repair shall be borne by the contractor.

• Maintenance includes all UPS maintenance, such as battery replacement, if required for optimal equipment performance.

d. The contractor will furnish a malfunction incident report to the laboratory upon completion of each maintenance call. The report will include, at a minimum, the following:

1. Date and time of arrival.

2. Serial number type and model numbers(s) of equipment.

3. Time spent for repair.

4. Description of malfunction and proof of repair.

e. Maintenance Support: Service repair person shall be locally based within the local geographical area.

f. Replacement of Laboratory Equipment: During the contract period, should the repair record of any laboratory equipment reflect a downtime of 10% or more of the normal working days in one calendar month, a determination will be made by the representative of the government to replace the initial laboratory equipment with new equipment. The responsibility of maintaining the equipment furnished in good condition shall be solely that of the contractor.

g. Failure Mean Time Disclosure: The contractor shall state the failure mean time

(between failure and mean time to repair) for each piece of equipment offered. The Contractor shall provide emergency backup equipment, if required.

h. FDA Approved Instruments and Methods: Only instruments which are FDA approved will be considered. Instruments must be operational and interface with VA Laboratory Computer systems and VA system updates. Test methods must be FDA approved with limited recalls due to product failures. This must be a "turn-key" system.

j. Operator Procedure Manuals: Operator and Service manuals along with CLSI compliant editable standard operating procedures (SOP) must be furnished for each instrument model supplied.

7. TRAINING AND TECHNICAL SERVICE TRAINING:

a. The contractor shall include offsite (manufacturer facility) training for One (1) operating personnel for each instrument installed and all automation system components at the time of installation of the contractor's equipment and each year thereafter that the contract remains in effect. User training is to include all costs of off-site training, i.e., transportation (air and ground), room, and board.

b. On-site training by vendor shall also be supplied to all laboratory staff as needed.

c. Vendor shall provide training to laboratory users on the data management system with either off site or in house training. On-site refresher training in renewal option years of the contract shall also be made available annually.

d. In addition, the contractor shall provide supplemental operating training to above government personnel, without additional charge to the government, upon installation of the update in equipment hardware or operating system software connected with the operation of an instrument already furnished.

8. INSTALLATION AND INITIAL SETUP:

a. Site Preparation: Site preparation specifications shall be furnished in writing by the contractor as a part of the equipment proposal. These specifications shall be in such detail as to ensure that the equipment to be installed shall operate efficiently and conform to the manufacturer's claimed specifications.

b. Space Requirements, System Specifications, ETC: Configuration of the proposed equipment must be able to conform to the space previously allotted for this function.

System specifications must be disclosed. Crossover from current to new instrumentation must be performed timely with no interruption of patient care services.

c. Ownership of Equipment: Ownership of the equipment shall remain with the contractor. All accessories (unused consumables, etc.) furnished by the contractor shall accompany the equipment when returned to the contractor. The contractor, upon expiration of order(s), at termination and/or replacement of equipment, shall remove the equipment. The contractor shall disconnect the analyzer (gas, water, air, etc.) and shall be responsible for decontamination of the system, packing and shipping required to remove the analyzer within ten (10) calendar days of request.

9. INSTALLATION PROCEDURES:

a. The contractor will be responsible for installation, which consists of inhouse delivery, positioning, and mounting of all equipment listed on the delivery order and connections of all equipment and interconnecting wiring and cabling, if applicable, in coordination with a facility Biomedical engineer.

b. Upon receipt of notice to proceed with installation, it shall be the contractor's responsibility to inform the Contracting Officer of any problems which may be anticipated in connection with installation, or which will affect optimum performance once installation is completed.

c. In the event that progress of the installation is interrupted through no fault of the contractor, the continuous installation referenced in the preceding paragraphs may be terminated until such time as the cause of delay has been eliminated, and then shall be resumed within 24 hours after the contractor has been notified that work may again proceed.

d. Upon completion of installation the equipment shall be turned over to the hospital for use. Final acceptance of the equipment and installation will be required by laboratory staff.

e. The contractor will provide equipment installation and possible reinstallation at minimal costs if the equipment is required to be moved due to future construction or laboratory redesign.

10. STANDARD AND ACCEPTANCE OF PERFORMANCE: This paragraph establishes a standard of performance that must be met before any equipment listed on the deliver order is accepted by the government. This also includes replacement, substitute machines and machines that are added or field modified after a system has completed a successful performance period.

a. The performance period shall begin on the installation date. It shall end when the equipment has met the standard of performance for a period of 30 consecutive calendar days by operating in conformance with the contractor's technical specification or as quoted in any contract at an effectiveness level of 99% or more. Operational use time for performance testing for a system is defined as the accumulated time during which the machine is in actual use. System failure downtime is that period of time when any machine in the system is inoperable due to equipment failure. Downtime for each incident shall start from the time the government makes a bona fide attempt to contact the contractor's designated representative at the prearranged contact point until the system or machine(s) is returned to the government in proper operating condition.

b. The government will maintain appropriate daily records to satisfy the requirements of this paragraph and shall notify the contractor in writing of the date of the first day of the successful performance period. Operations use time and downtime shall be measured in hours and whole minutes.

GOVERNMENT'S RESPONSIBILITY: The user will perform routine maintenance and cleaning as required in the manufacturer's operation and maintenance instructions. The user will maintain appropriate daily records to satisfy the requirements of this section.

B.3 SCHEDULE - OKCVAHCS

Oklahoma City VA Medical Center Year 1: April 1, 2024 through March 31, 2025

CLIN SUBCLIN TEST DESCRIPTION

ITEM

NUMBER

ESTIMATED

ANNUAL

TEST

QUANTITY CPT ($)

TOTAL

YEARLY

ESTIMATED

COST ($)

0001 AA Aerobic bottles (w/ antibiotic neutralization)

0002 AA Anaerobic bottles (w/ antibiotic neutralization or resin)

0003 AA Subculture Units 100/Box 0 N/A N/A

0004 AA Mycobacteria Processing (for sources other than blood)

0005 AA MP antibiotic supplement kit (100 test/box)

0006 AA Gram-positive susceptibility (AST)

0007 AA Gram-negative susceptibility (AST)

0008 AA Yeast Susceptibility A 300

0009 AA Gram Negative ID 10

0010 AA Gram Positive ID 2

0011 AA Anaerobic ID 2

0012 AA Neisseria/Haemophilus ID 2

0013 AA Yeast ID 2

Estimated Year 1 Total:

Oklahoma City VA Medical Center Year 2: April 1, 2025 through March 31, 2026

CLIN SUBCLIN TEST DESCRIPTION

ITEM

NUMBER

ESTIMATED

ANNUAL

TEST

QUANTITY CPT ($)

TOTAL

YEARLY

ESTIMATED

COST ($)

1001 AA Aerobic bottles (w/ antibiotic neutralization)

1002 AA Anaerobic bottles (w/ antibiotic neutralization or resin)

1003 AA Subculture Units 100/Box 0 N/A N/A

1004 AA Mycobacteria Processing (for sources other than blood)

1005 AA MP antibiotic supplement kit (100 test/box)

1006 AA Gram-positive susceptibility (AST)

1007 AA Gram-negative susceptibility (AST)

1008 AA Yeast Susceptibility A 300

1009 AA Gram Negative ID 10

1010 AA Gram Positive ID 2

1011 AA Anaerobic ID 2

1012 AA Neisseria/Haemophilus ID 2

1013 AA Yeast ID 2

Estimated Year 2 Total:

Year 3: April 1, 2026 through March 31, 2027

CLIN SUBCLIN TEST DESCRIPTION

ITEM

NUMBER

ESTIMATED

ANNUAL

TEST

QUANTITY CPT ($)

TOTAL

YEARLY

ESTIMATED

COST ($)

2001 AA Aerobic bottles (w/ antibiotic neutralization)

2002 AA Anaerobic bottles (w/ antibiotic neutralization or resin)

2003 AA Subculture Units 100/Box 0 N/A N/A

2004 AA Mycobacteria Processing (for sources other than blood)

2005 AA MP antibiotic supplement kit (100 test/box)

2006 AA Gram-positive susceptibility (AST)

2007 AA Gram-negative susceptibility (AST)

2008 AA Yeast Susceptibility A 300

2009 AA Gram Negative ID 10

2010 AA Gram Positive ID 2

2011 AA Anaerobic ID 2

2012 AA Neisseria/Haemophilus ID 2

2013 AA Yeast ID 2

Estimated Year 3 Total:

Year 4: April 1, 2027 through March 31, 2028

CLIN SUBCLIN TEST DESCRIPTION

ITEM

NUMBER

ESTIMATED

ANNUAL

TEST

QUANTITY CPT ($)

TOTAL

YEARLY

ESTIMATED

COST ($)

3001 AA Aerobic bottles (w/ antibiotic neutralization)

3002 AA Anaerobic bottles (w/ antibiotic neutralization or resin)

3003 AA Subculture Units 100/Box 0 N/A N/A

3004 AA Mycobacteria Processing (for sources other than blood)

3005 AA MP antibiotic supplement kit (100 test/box)

3006 AA Gram-positive susceptibility (AST)

3007 AA Gram-negative susceptibility (AST)

3008 AA Yeast Susceptibility A 300

3009 AA Gram Negative ID 10

3010 AA Gram Positive ID 2

3011 AA Anaerobic ID 2

3012 AA Neisseria/Haemophilus ID 2

3013 AA Yeast ID 2

Estimated Year 4 Total:

Year 5: April 1, 2028 through March 31, 2029

CLIN SUBCLIN TEST DESCRIPTION

ITEM

NUMBER

ESTIMATED

ANNUAL

TEST

QUANTITY CPT ($)

TOTAL

YEARLY

ESTIMATED

COST ($)

4001 AA Aerobic bottles (w/ antibiotic neutralization)

4002 AA Anaerobic bottles (w/ antibiotic neutralization or resin)

4003 AA Subculture Units 100/Box 0 N/A N/A

4004 AA Mycobacteria Processing (for sources other than blood)

4005 AA MP antibiotic supplement kit (100 test/box)

4006 AA Gram-positive susceptibility (AST)

4007 AA Gram-negative susceptibility (AST)

4008 AA Yeast Susceptibility A 300

4009 AA Gram Negative ID 10

4010 AA Gram Positive ID 2

4011 AA Anaerobic ID 2

4012 AA Neisseria/Haemophilus ID 2

4013 AA Yeast ID 2

Estimated Year 5 Total:

CLIN SUBCLIN TEST DESCRIPTION

ITEM

NUMBER

ESTIMATED

ANNUAL

TEST

QUANTITY CPT ($)

TOTAL

YEARLY

ESTIMATED

COST ($)

5001 AA Aerobic bottles (w/ antibiotic neutralization)

5002 AA Anaerobic bottles (w/ antibiotic neutralization or resin)

5003 AA Subculture Units 100/Box 0 N/A N/A

5004 AA Mycobacteria Processing (for sources other than blood)

5005 AA MP antibiotic supplement kit (100 test/box)

5006 AA Gram-positive susceptibility (AST)

5007 AA Gram-negative susceptibility (AST)

5008 AA Yeast Susceptibility A 300

5009 AA Gram Negative ID 10

5010 AA Gram Positive ID 2

5011 AA Anaerobic ID 2

5012 AA Neisseria/Haemophilus ID 2

5013 AA Yeast ID 2

Estimated Year 6 Total:

Year 7: April 1, 2030 through March 31, 2031

CLIN SUBCLIN TEST DESCRIPTION

ITEM

NUMBER

ESTIMATED

ANNUAL

TEST

QUANTITY CPT ($)

TOTAL

YEARLY

ESTIMATED

COST ($)

AA Aerobic bottles (w/ antibiotic neutralization)

AA Anaerobic bottles (w/ antibiotic neutralization or resin)

6003 AA Subculture Units 100/Box 0 N/A N/A

AA Mycobacteria Processing (for sources other than blood)

AA MP antibiotic supplement kit (100 test/box)

AA Gram-positive susceptibility (AST)

AA Gram-negative susceptibility (AST)

6008 AA Yeast Susceptibility A 300

6009 AA Gram Negative ID 10

6010 AA Gram Positive ID 2

6011 AA Anaerobic ID 2

6012 AA Neisseria/Haemophilus ID 2

6013 AA Yeast ID 2

Estimated Year 7 Total:

Oklahoma City Year 1 Estimated Total: __________________________

Oklahoma City Year 2 Estimated Total: __________________________

Oklahoma City Year 3 Estimated Total: __________________________

Oklahoma City Year 4 Estimated Total: __________________________

Oklahoma City Year 5 Estimated Total: __________________________

Oklahoma City Year 6 Estimated Total: __________________________

Oklahoma City Year 7 Estimated Total: __________________________

Estimated 7-Year Total Cost for Oklahoma City: ___________________________

B.4 SCHEDULE - EOKVAHCS

Eastern Oklahoma VA Health Care System (Muskogee) Year 1: April 1, 2024 through March 31, 2025

CLIN SUBCLIN TEST DESCRIPTION

ITEM

NUMBER

ESTIMATED

ANNUAL

TEST

QUANTITY CPT ($)

TOTAL

YEARLY

ESTIMATED

COST ($)

0001 AB Aerobic bottles (w/ antibiotic neutralization)

0002 AB Anaerobic bottles (w/ antibiotic neutralization or resin)

0003 AB Subculture Units 100/Box 500

0004 AB Mycobacteria Processing (for sources other than blood)

0 N/A N/A

0005 AB MP antibiotic supplement kit (100 test/box)

0 N/A N/A

0006 AB Gram-positive susceptibility (AST)

0007 AB Gram-negative susceptibility (AST)

0008 AB Yeast Susceptibility A 0 N/A N/A

0009 AB Gram Negative ID 2500

0010 AB Gram Positive ID 1500

0011 AB Anaerobic ID 0 N/A N/A

0012 AB Neisseria/Haemophilus ID 100

0013 AB Yeast ID 0 N/A N/A

Estimated Year 1 Total:

Eastern Oklahoma VA Health Care System (Muskogee) Year 2: April 1, 2025 through March 31, 2026

CLIN SUBCLIN TEST DESCRIPTION

ITEM

NUMBER

ESTIMATED

ANNUAL

TEST

QUANTITY CPT ($)

TOTAL

YEARLY

ESTIMATED

COST ($)

1001 AB Aerobic bottles (w/ antibiotic neutralization)

1002 AB Anaerobic bottles (w/ antibiotic neutralization or resin)

1003 AB Subculture Units 100/Box 500

1004 AB Mycobacteria Processing (for sources other than blood)

0 N/A N/A

1005 AB MP antibiotic supplement kit (100 test/box)

0 N/A N/A

1006 AB Gram-positive susceptibility (AST)

1007 AB Gram-negative susceptibility (AST)

1008 AB Yeast Susceptibility A 0 N/A N/A

1009 AB Gram Negative ID 2500

1010 AB Gram Positive ID 1500

1011 AB Anaerobic ID 0 N/A N/A

1012 AB Neisseria/Haemophilus ID 100

1013 AB Yeast ID 0 N/A N/A

Estimated Year 2 Total:

Year 3: April 1, 2026 through March 31, 2027

CLIN SUBCLIN TEST DESCRIPTION

ITEM

NUMBER

ESTIMATED

ANNUAL

TEST

QUANTITY CPT ($)

TOTAL

YEARLY

ESTIMATED

COST ($)

2001 AB Aerobic bottles (w/ antibiotic neutralization)

2002 AB Anaerobic bottles (w/ antibiotic neutralization or resin)

2003 AB Subculture Units 100/Box 500

2004 AB Mycobacteria Processing (for sources other than blood)

0 N/A N/A

2005 AB MP antibiotic supplement kit (100 test/box)

0 N/A N/A

2006 AB Gram-positive susceptibility (AST)

2007 AB Gram-negative susceptibility (AST)

2008 AB Yeast Susceptibility A 0 N/A N/A

2009 AB Gram Negative ID 2500

2010 AB Gram Positive ID 1500

2011 AB Anaerobic ID 0 N/A N/A

2012 AB Neisseria/Haemophilus ID 100

2013 AB Yeast ID 0 N/A N/A

Estimated Year 3 Total:

Year 4: April 1, 2027 through March 31, 2028

CLIN SUBCLIN TEST DESCRIPTION

ITEM

NUMBER

ESTIMATED

ANNUAL

TEST

QUANTITY CPT ($)

TOTAL

YEARLY

ESTIMATED

COST ($)

3001 AB Aerobic bottles (w/ antibiotic neutralization)

3002 AB Anaerobic bottles (w/ antibiotic neutralization or resin)

3003 AB Subculture Units 100/Box 500

3004 AB Mycobacteria Processing (for sources other than blood)

0 N/A N/A

3005 AB MP antibiotic supplement kit (100 test/box)

0 N/A N/A

3006 AB Gram-positive susceptibility (AST)

3007 AB Gram-negative susceptibility (AST)

3008 AB Yeast Susceptibility A 0 N/A N/A

3009 AB Gram Negative ID 2500

3010 AB Gram Positive ID 1500

3011 AB Anaerobic ID 0 N/A N/A

3012 AB Neisseria/Haemophilus ID 100

3013 AB Yeast ID 0 N/A N/A

Estimated Year 4 Total:

Year 5: April 1, 2028 through March 31, 2029

CLIN SUBCLIN TEST DESCRIPTION

ITEM

NUMBER

ESTIMATED

ANNUAL

TEST

QUANTITY CPT ($)

TOTAL

YEARLY

ESTIMATED

COST ($)

4001 AB Aerobic bottles (w/ antibiotic neutralization)

4002 AB Anaerobic bottles (w/ antibiotic neutralization or resin)

4003 AB Subculture Units 100/Box 500

4004 AB Mycobacteria Processing (for sources other than blood)

0 N/A N/A

4005 AB MP antibiotic supplement kit (100 test/box)

0 N/A N/A

4006 AB Gram-positive susceptibility (AST)

4007 AB Gram-negative susceptibility (AST)

4008 AB Yeast Susceptibility A 0 N/A N/A

4009 AB Gram Negative ID 2500

4010 AB Gram Positive ID 1500

4011 AB Anaerobic ID 0 N/A N/A

4012 AB Neisseria/Haemophilus ID 100

4013 AB Yeast ID 0 N/A N/A

Estimated Year 5 Total:

CLIN SUBCLIN TEST DESCRIPTION

ITEM

NUMBER

ESTIMATED

ANNUAL

TEST

QUANTITY CPT ($)

TOTAL

YEARLY

ESTIMATED

COST ($)

5001 AB Aerobic bottles (w/ antibiotic neutralization)

5002 AB Anaerobic bottles (w/ antibiotic neutralization or resin)

5003 AB Subculture Units 100/Box 500

5004 AB Mycobacteria Processing (for sources other than blood)

0 N/A N/A

5005 AB MP antibiotic supplement kit (100 test/box)

0 N/A N/A

5006 AB Gram-positive susceptibility (AST)

5007 AB Gram-negative susceptibility (AST)

5008 AB Yeast Susceptibility A 0 N/A N/A

5009 AB Gram Negative ID 2500

5010 AB Gram Positive ID 1500

5011 AB Anaerobic ID 0 N/A N/A

5012 AB Neisseria/Haemophilus ID 100

5013 AB Yeast ID 0 N/A N/A

Estimated Year 6 Total:

Year 7: April 1, 2030 through March 31, 2031

CLIN SUBCLIN TEST DESCRIPTION

ITEM

NUMBER

ESTIMATED

ANNUAL

TEST

QUANTITY CPT ($)

TOTAL

YEARLY

ESTIMATED

COST ($)

AB Aerobic bottles (w/ antibiotic neutralization)

AB Anaerobic bottles (w/ antibiotic neutralization or resin)

6003 AB Subculture Units 100/Box 500

AB Mycobacteria Processing (for sources other than blood)

0 N/A N/A

AB MP antibiotic supplement…